Signaling pathway may help predict immunotherapy response in glioblastoma. Northwestern Medicine scientists have uncovered a biological mechanism that helps explain why most patients with glioblastoma fail to respond to immunotherapy, according to their study published in Nature Communications.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Northwestern Medicine scientists have uncovered a biological mechanism that helps explain why most patients with glioblastoma fail to respond to immunotherapy, according to their study published in Nature Communications.
- Ponto de atenção: signaling.
- Ponto de atenção: pathway.
- Ponto de atenção: help.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
